Tempus AI Diagnostics CEO Thomas Edward Schoenherr disposes of $873,885 in common shares
Bitget2026/09/29 20:15- Tempus AI officer Thomas Edward Schoenherr, CEO of Diagnostics, sold 10,281 Class A common shares on Sept. 25, 2026.
- Sale price USD 85 per share.
- Directly held stake fell to 76,740 shares following the transaction.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The $1,999 iPhone drives foldable screen market expansion! Counterpoint estimates that Apple (AAPL.US) iPhone Duo will sell 6 million units this year.
The market research firm Counterpoint Research stated that Apple is expected to sell about 6 million units of the iPhone Duo this year. This is the industry's first sales forecast for this new foldable device.
Omar Kanji joins Brevan Howard as Head of Digital Asset Business Growth Investment.

AUD/USD Price Forecast: Holds slight recovery from 0.6960
1.3%: Germany’s Retail Sales rise by less than expected in August